200 related articles for article (PubMed ID: 36006428)
21. Prognostic significance of FDG-PET in relapsed or refractory classical Hodgkin lymphoma treated with standard salvage chemotherapy and autologous stem cell transplantation.
Smeltzer JP; Cashen AF; Zhang Q; Homb A; Dehdashti F; Abboud CN; Dipersio JF; Stockerl-Goldstein KE; Uy GL; Vij R; Westervelt P; Bartlett NL; Fehniger TA
Biol Blood Marrow Transplant; 2011 Nov; 17(11):1646-52. PubMed ID: 21601641
[TBL] [Abstract][Full Text] [Related]
22. Combined clinical and specific positron emission tomography/computed tomography-based radiomic features and machine-learning model in prediction of thymoma risk groups.
Ozkan E; Orhan K; Soydal C; Kahya Y; Seckin Tunc S; Celik O; Dizbay Sak S; Kayi Cangir A
Nucl Med Commun; 2022 May; 43(5):529-539. PubMed ID: 35234213
[TBL] [Abstract][Full Text] [Related]
23.
Li H; Xu C; Xin B; Zheng C; Zhao Y; Hao K; Wang Q; Wahl RL; Wang X; Zhou Y
Theranostics; 2019; 9(16):4730-4739. PubMed ID: 31367253
[No Abstract] [Full Text] [Related]
24. Preoperative prediction of regional lymph node metastasis of colorectal cancer based on
He J; Wang Q; Zhang Y; Wu H; Zhou Y; Zhao S
Ann Nucl Med; 2021 May; 35(5):617-627. PubMed ID: 33738763
[TBL] [Abstract][Full Text] [Related]
25. Texture analysis of 18F-FDG PET/CT and CECT: Prediction of refractoriness of Hodgkin lymphoma with mediastinal bulk involvement.
Abenavoli EM; Linguanti F; Anichini M; Miele V; Mungai F; Palazzo M; Nassi L; Puccini B; Romano I; Sordi B; Sciagrà R; Simontacchi G; Vannucchi AM; Berti V
Hematol Oncol; 2024 Mar; 42(2):e3261. PubMed ID: 38454623
[TBL] [Abstract][Full Text] [Related]
26. Prediction of lung malignancy progression and survival with machine learning based on pre-treatment FDG-PET/CT.
Huang B; Sollee J; Luo YH; Reddy A; Zhong Z; Wu J; Mammarappallil J; Healey T; Cheng G; Azzoli C; Korogodsky D; Zhang P; Feng X; Li J; Yang L; Jiao Z; Bai HX
EBioMedicine; 2022 Aug; 82():104127. PubMed ID: 35810561
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic evaluation value of (18)F-FDG PET-CT in Hodgkin's lymphoma after treatment].
Wan H; Liu P; Liang Y; Jiang SY; Lyu L; Zhang ZW; Wu N; Liu Y
Zhonghua Zhong Liu Za Zhi; 2021 Dec; 43(12):1275-1281. PubMed ID: 34915636
[No Abstract] [Full Text] [Related]
28. Pretherapy 18F-fluorodeoxyglucose positron emission tomography/computed tomography robust radiomic features predict overall survival in non-small cell lung cancer.
Mostafa R; Abdelsamie Kandeel A; Abd Elkareem M; Nardo L; Abdelhafez YG
Nucl Med Commun; 2022 May; 43(5):540-548. PubMed ID: 35190518
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Value of 2-[(18)F] Fluoro-2-deoxy-D-glucose Positron Emission Tomography-Computed Tomography Scan Carried out During and After Radiation Therapy for Head and Neck Cancer Using Visual Therapy Response Interpretation Criteria.
Min M; Lin P; Lee M; Ho Shon I; Lin M; Forstner D; Tieu MT; Chicco A; Bray V; Fowler A
Clin Oncol (R Coll Radiol); 2016 Jun; 28(6):393-401. PubMed ID: 26782837
[TBL] [Abstract][Full Text] [Related]
30. Early determination of prognosis by interim 3'-deoxy-3'-18F-fluorothymidine PET in patients with non-Hodgkin lymphoma.
Lee H; Kim SK; Kim YI; Kim TS; Kang SH; Park WS; Yun T; Eom HS
J Nucl Med; 2014 Feb; 55(2):216-22. PubMed ID: 24365650
[TBL] [Abstract][Full Text] [Related]
31. Predicting pathological highly invasive lung cancer from preoperative [
Onozato Y; Iwata T; Uematsu Y; Shimizu D; Yamamoto T; Matsui Y; Ogawa K; Kuyama J; Sakairi Y; Kawakami E; Iizasa T; Yoshino I
Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):715-726. PubMed ID: 36385219
[TBL] [Abstract][Full Text] [Related]
32. Relationship between semiquantitative
Kahle XU; Montes de Jesus FM; Kwee TC; van Meerten T; Diepstra A; Rosati S; Glaudemans AWJM; Noordzij W; Plattel WJ; Nijland M
Sci Rep; 2019 Jul; 9(1):11073. PubMed ID: 31363153
[TBL] [Abstract][Full Text] [Related]
33. Automated quantification of reference levels in liver and mediastinal blood pool for the Deauville therapy response classification using FDG-PET/CT in Hodgkin and non-Hodgkin lymphomas.
Sadik M; Lind E; Polymeri E; Enqvist O; Ulén J; Trägårdh E
Clin Physiol Funct Imaging; 2019 Jan; 39(1):78-84. PubMed ID: 30284376
[TBL] [Abstract][Full Text] [Related]
34. Ability of
Ou X; Wang J; Zhou R; Zhu S; Pang F; Zhou Y; Tian R; Ma X
Contrast Media Mol Imaging; 2019; 2019():4507694. PubMed ID: 30930700
[No Abstract] [Full Text] [Related]
35. Prediction of local relapse and distant metastasis in patients with definitive chemoradiotherapy-treated cervical cancer by deep learning from [
Shen WC; Chen SW; Wu KC; Hsieh TC; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yen KY; Kao CH
Eur Radiol; 2019 Dec; 29(12):6741-6749. PubMed ID: 31134366
[TBL] [Abstract][Full Text] [Related]
36. Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT.
Brown PJ; Zhong J; Frood R; Currie S; Gilbert A; Appelt AL; Sebag-Montefiore D; Scarsbrook A
Eur J Nucl Med Mol Imaging; 2019 Dec; 46(13):2790-2799. PubMed ID: 31482428
[TBL] [Abstract][Full Text] [Related]
37. A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [
Zhang X; Chen L; Jiang H; He X; Feng L; Ni M; Ma M; Wang J; Zhang T; Wu S; Zhou R; Jin C; Zhang K; Qian W; Chen Z; Zhuo C; Zhang H; Tian M
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1298-1310. PubMed ID: 34651227
[TBL] [Abstract][Full Text] [Related]
38. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
[TBL] [Abstract][Full Text] [Related]
39. Prognostic role of pretreatment
Yang T; Liu S; Zuo R; Liang H; Xu L; Wang Z; Chen X; Pang H
BMC Med Imaging; 2023 Jan; 23(1):12. PubMed ID: 36681824
[TBL] [Abstract][Full Text] [Related]
40. Impact of
Haider SP; Zeevi T; Sharaf K; Gross M; Mahajan A; Kann BH; Judson BL; Prasad ML; Burtness B; Aboian M; Canis M; Reichel CA; Baumeister P; Payabvash S
J Nucl Med; 2024 May; 65(5):803-809. PubMed ID: 38514087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]